e8va12b
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
Ardea Biosciences, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
(State of incorporation or organization)
|
|
94-3200380
(I.R.S. Employer Identification no.) |
|
|
|
2131 Palomar Airport Road, Suite 300
Carlsbad, California
(Address of principal executive offices)
|
|
92011
(Zip code) |
|
|
|
If this form relates to the
registration of a class of securities
pursuant to Section 12(b) of the
Exchange Act and is effective pursuant
to General Instruction A.(c), check the
following box. þ
|
|
If this form
relates to the
registration of a
class of securities
pursuant to Section
12(g) of the
Exchange Act and is
effective pursuant
to General
Instruction A.(d),
check the following
box. ¨ |
Securities Act registration statement file number to which the form relates: __________ (if applicable)
Securities to be registered pursuant to Section 12(b) of the Act:
|
|
|
Title of each class |
|
Name of exchange on which |
to be so registered |
|
each class is to be registered |
Common Stock, $0.001 par value per share
|
|
The NASDAQ Stock Market LLC |
Securities to be registered pursuant to Section 12(g) of the Act:
Not applicable
(Title of class)
Item 1. Description of Registrants Securities to be Registered.
A description of the common stock, $0.001 par value per share (the Common Stock), of Ardea
Biosciences, Inc., a Delaware corporation (the Registrant), to be registered hereunder is
contained in the section entitled Description of Capital Stock in the prospectus included in the
Registrants Form S-1 Registration Statement (File No. 333-114451), initially filed with the
Securities and Exchange Commission on April 14, 2004, as amended from time to time (the
Registration Statement), and is incorporated herein by reference.
Item 2. Exhibits.
None.
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act of
1934, the Registrant has duly caused this registration statement to be signed on its behalf by the
undersigned, thereto duly authorized.
|
|
|
|
|
|
ARDEA BIOSCIENCES, INC.
|
|
Date: October 9, 2007 |
By: |
/s/ Barry D. Quart
|
|
|
|
Barry D. Quart, Pharm. D |
|
|
|
Chief Executive Officer |
|
|